The short list of nominees also included Sputnik V developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology and the drug produced by AstraZeneca, a British-Swedish company, jointly with the University of Oxford
‘Strange choice’: Sputnik V developer casts doubt on World Vaccine Congress' Moderna pick
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться